VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 624 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $311,000 | -5.5% | 9,695 | -13.1% | 0.00% | -20.0% |
| Q3 2021 | $329,000 | -9.4% | 11,159 | +4.4% | 0.01% | 0.0% |
| Q2 2021 | $363,000 | -2.4% | 10,692 | -6.7% | 0.01% | -16.7% |
| Q1 2021 | $372,000 | -44.1% | 11,455 | -38.1% | 0.01% | -45.5% |
| Q4 2020 | $666,000 | -8.6% | 18,502 | -0.6% | 0.01% | -21.4% |
| Q3 2020 | $729,000 | +2.1% | 18,612 | -4.4% | 0.01% | -6.7% |
| Q2 2020 | $714,000 | +41.7% | 19,469 | -10.9% | 0.02% | +25.0% |
| Q1 2020 | $504,000 | -29.9% | 21,856 | -11.0% | 0.01% | -20.0% |
| Q4 2019 | $719,000 | +15.6% | 24,558 | +5.4% | 0.02% | +7.1% |
| Q3 2019 | $622,000 | +640.5% | 23,302 | +536.0% | 0.01% | +600.0% |
| Q3 2017 | $84,000 | -16.8% | 3,664 | -19.6% | 0.00% | -33.3% |
| Q2 2017 | $101,000 | +1.0% | 4,558 | +3.9% | 0.00% | 0.0% |
| Q1 2017 | $100,000 | – | 4,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |